187 related articles for article (PubMed ID: 31610798)
1. Transcriptional activation of CBFβ by CDK11
Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z
Cell Commun Signal; 2019 Oct; 17(1):125. PubMed ID: 31610798
[TBL] [Abstract][Full Text] [Related]
2. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
3. Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation.
Duan Z; Zhang J; Choy E; Harmon D; Liu X; Nielsen P; Mankin H; Gray NS; Hornicek FJ
Clin Cancer Res; 2012 Sep; 18(17):4580-8. PubMed ID: 22791884
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth.
Zhou Y; Han C; Li D; Yu Z; Li F; Li F; An Q; Bai H; Zhang X; Duan Z; Kan Q
Sci Rep; 2015 May; 5():10433. PubMed ID: 25990212
[TBL] [Abstract][Full Text] [Related]
5. Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
Feng Y; Sassi S; Shen JK; Yang X; Gao Y; Osaka E; Zhang J; Yang S; Yang C; Mankin HJ; Hornicek FJ; Duan Z
J Orthop Res; 2015 Feb; 33(2):199-207. PubMed ID: 25348612
[TBL] [Abstract][Full Text] [Related]
6. Critical role of CDK11(p58) in human breast cancer growth and angiogenesis.
Chi Y; Huang S; Peng H; Liu M; Zhao J; Shao Z; Wu J
BMC Cancer; 2015 Oct; 15():701. PubMed ID: 26470709
[TBL] [Abstract][Full Text] [Related]
7. Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development.
Li T; Inoue A; Lahti JM; Kidd VJ
Mol Cell Biol; 2004 Apr; 24(8):3188-97. PubMed ID: 15060143
[TBL] [Abstract][Full Text] [Related]
8. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
[TBL] [Abstract][Full Text] [Related]
9. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 11(p110) activity in the absence of CK2.
Sachs NA; Vaillancourt RR
Biochim Biophys Acta; 2003 Dec; 1624(1-3):98-108. PubMed ID: 14642819
[TBL] [Abstract][Full Text] [Related]
11. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.
Zhou Y; Shen JK; Hornicek FJ; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(26):40846-40859. PubMed ID: 27049727
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.
Loyer P; Trembley JH; Grenet JA; Busson A; Corlu A; Zhao W; Kocak M; Kidd VJ; Lahti JM
J Biol Chem; 2008 Mar; 283(12):7721-32. PubMed ID: 18216018
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.
Liao Y; Sassi S; Halvorsen S; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
Sci Rep; 2017 Mar; 7():43941. PubMed ID: 28262798
[TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase 11 interacts with 14-3-3 proteins.
Feng Y; Qi W; Martinez J; Nelson MA
Biochem Biophys Res Commun; 2005 Jun; 331(4):1503-9. PubMed ID: 15883043
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Transcriptional activation of CBFβ by CDK11
Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z
Cell Commun Signal; 2019 Oct; 17(1):138. PubMed ID: 31665012
[TBL] [Abstract][Full Text] [Related]
16. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.
Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA
Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810
[TBL] [Abstract][Full Text] [Related]
17. Core binding factor beta (Cbfβ) controls the balance of chondrocyte proliferation and differentiation by upregulating Indian hedgehog (Ihh) expression and inhibiting parathyroid hormone-related protein receptor (PPR) expression in postnatal cartilage and bone formation.
Tian F; Wu M; Deng L; Zhu G; Ma J; Gao B; Wang L; Li YP; Chen W
J Bone Miner Res; 2014 Jul; 29(7):1564-1574. PubMed ID: 24821091
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
19. CDK11 complexes promote pre-mRNA splicing.
Hu D; Mayeda A; Trembley JH; Lahti JM; Kidd VJ
J Biol Chem; 2003 Mar; 278(10):8623-9. PubMed ID: 12501247
[TBL] [Abstract][Full Text] [Related]
20. CDK11(p58) is required for the maintenance of sister chromatid cohesion.
Hu D; Valentine M; Kidd VJ; Lahti JM
J Cell Sci; 2007 Jul; 120(Pt 14):2424-34. PubMed ID: 17606997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
